These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases. Raoof M; Dellinger T Ann Surg Oncol; 2022 Jan; 29(1):186-187. PubMed ID: 34312799 [No Abstract] [Full Text] [Related]
3. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC). Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279 [TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases. Bakkers C; Lurvink RJ; van Erning FN; Nienhuijs SW; de Hingh IHJT Ann Surg Oncol; 2021 Dec; 28(13):9084-9085. PubMed ID: 34091776 [No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Prognostic Factors in Surgically Treated Peritoneal Metastases from Colorectal Cancer. Baratti D; Deraco M Ann Surg Oncol; 2021 Jun; 28(6):3343-3344. PubMed ID: 33063262 [No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases. Bhatt A; Képénékian V; Benzerdjeb N; Glehen O Ann Surg Oncol; 2021 Jul; 28(7):3850-3851. PubMed ID: 33211229 [No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results? García-Fadrique A Ann Surg Oncol; 2022 Jan; 29(1):203-204. PubMed ID: 34435299 [No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Synchronous Liver and Peritoneal Metastasis From Colorectal Cancer. Mor E; Adileh M; Ariche A; Nissan A Ann Surg Oncol; 2021 Jun; 28(6):3330-3331. PubMed ID: 33005991 [No Abstract] [Full Text] [Related]
9. ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis. Shida D Ann Surg Oncol; 2018 Dec; 25(Suppl 3):842-843. PubMed ID: 30324473 [No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer? Kepenekian V; Kefleyesus A; Passot G; Rousset P; Benzerdjeb N; You B; Peron J; Glehen O Ann Surg Oncol; 2023 Jun; 30(6):3316-3317. PubMed ID: 36752969 [No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value. El Asmar A; Liberale G Ann Surg Oncol; 2023 Jun; 30(6):3329-3330. PubMed ID: 36735085 [No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Localized Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer-Are They Candidates for Radical Resection? Kunitomo A; Ouchi A Ann Surg Oncol; 2023 Dec; 30(13):8520-8521. PubMed ID: 37668760 [No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin. El Asmar A; Liberale G Ann Surg Oncol; 2023 Mar; 30(3):1870-1871. PubMed ID: 36336734 [No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis. Shida D Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024 [No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases. Vierra M; Bansal VV; Shergill A; Turaga KK; Eng OS Ann Surg Oncol; 2024 Jan; 31(1):655-656. PubMed ID: 37803088 [No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection. Kepenekian V; Kefleyesus A; Passot G; Rousset P; Péron J; Glehen O Ann Surg Oncol; 2023 Jul; 30(7):4455-4456. PubMed ID: 36907959 [No Abstract] [Full Text] [Related]
17. [Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases]. Graversen M; Detlefsen S; Knudsen AØ; Pfeiffer P; Mortensen MB Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610840 [TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection. Kepenekian V; Péron J; You B; Glehen O Ann Surg Oncol; 2022 Mar; 29(3):2114-2115. PubMed ID: 34705141 [No Abstract] [Full Text] [Related]
19. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC). Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425 [TBL] [Abstract][Full Text] [Related]